More articles from Oncology: Clinical Diagnosis: Prostate/GU

You have access
Preliminary evaluation of 18F-NaF and 18F-FDG PET/CT in detection of metastatic disease in men with PSA relapse after treatment for localized primary prostate cancer
Hossein Jadvar, Bhushan Desai, Peter Conti, Tanya Dorff, Mitchell Gross and David Quinn

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1916;
You have access
FCH PET/CT in the assessment of recurrent prostate cancer: Correlation with PSA level
Mohsen Beheshti, Rasoul Zakavi, Silke Haim, Martin Steinmair, Peter Waldenberger, Iris Wolf, Michael Nader, Wolfgang Loidl and Werner Langsteger

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1913;
You have access
18FDG-PET/CT in the assessment of lymph node involvement in patients with invasive penile carcinoma
Isabelle Souillac, Francoise Kraeber-Bodere, Olivier Bouchot, Jérôme Rigaud, Thomas Carlier and Catherine Ansquer

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1905;
You have access
The importance of SPECT-CT in sentinel lymph node detection with prostate cancer patients
Ildikó Balogh, András Páczelt, József Varga, Károly Pócza and Zoltán Galler

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1912;
You have access
Clinical value of [F-18]-Fluorodeoxyglucose PET/CT in locally recurrent and metastatic bladder transitional cell carcinoma
Yun Jung Choi, Won Jun Kang, Arthur Cho, Hyo Jung Seo, Hyun Jeong Kim, Mijin Yun and Jong Doo Lee

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1904;
You have access
Value of 18F-FDG in the assessment of patients with upper tract urothelial carcinoma
Yamin Dou, Christopher Tretter, Charles Allison, Brady McKee and Edward Pinkus

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1917;
You have access
Treatment response assessment of metastatic prostate cancer with FDG PET/CT
Hossein Jadvar, Bhushan Desai, David Quinn, Tanya Dorff, Jacek Pinski, Peter Conti and Susan Groshen

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1908;
You have access
Restaging of penile cancer patients with 18F-FDG PET/CT
Yamin Dou, Edward Pinkus, Charles Allison, Brady McKee, Leonard Zinman and Jill Buckley

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1899;
You have access
The role of FDG PET/CT in testicular cancer
Gary Cook, Aslam Sohaib, Sue Chua, Val Lewington and Robert Huddart

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1914;
You have access
Impact of fluorocholine(18F) PET/CT in case of occult recurrence of prostate cancer
Jean-Noel Talbot, Virginie Huchet, Caroline Rousseau, Alexandre Cochet, Pierre Olivier, Frederic Courbon, Herve Foehrenbach and Valerie Nataf

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1911;

Main menu

User menu

Search

More articles from Oncology: Clinical Diagnosis: Prostate/GU

Pages